Effects of Rimonabant on Lipid Metabolism in Mice
Author Information
Author(s): Hu Chunxiu, Wei Heng, van den Hoek Anita M., Wang Mei, van der Heijden Rob, Spijksma Gerwin, Reijmers Theo H., Bouwman Jildau, Wopereis Suzan, Havekes Louis M., Verheij Elwin, Hankemeier Thomas, Xu Guowang, van der Greef Jan
Primary Institution: CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
Hypothesis
The rimonabant intervention on early obesity of ApoE*3Leiden.CETP mice would affect plasma and hepatic lipid metabolism relative to the non-treated controls.
Conclusion
Rimonabant treatment led to moderate effects on body weight and lipid metabolism in early-stage obesity in mice.
Supporting Evidence
- Rimonabant induced a significant body weight loss of 9.4%.
- Plasma total cholesterol was reduced by 24%.
- Distinct lipid patterns were observed between treated and non-treated mice.
Takeaway
This study looked at how a drug called rimonabant affects fat and weight in mice that are a bit overweight. It found that the drug helps reduce weight and some types of fat.
Methodology
A four-week parallel controlled intervention was conducted on transgenic mice using liquid chromatography and mass spectrometry to analyze lipid responses.
Limitations
The study was limited by the early stage of obesity in the animal model, which may not fully represent the effects in more advanced obesity.
Participant Demographics
16 female ApoE*3Leiden.CETP transgenic mice aged 6-10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website